L934-0507 Screening compound: 4-fluoro-N-(5-{5-oxo-1-[4-(trifluoromethoxy)phenyl]pyrrolidin-3-yl}-1,3,4-oxadiazol-2-yl)benzamide

L934-0507 Screening compound: 4-fluoro-N-(5-{5-oxo-1-[4-(trifluoromethoxy)phenyl]pyrrolidin-3-yl}-1,3,4-oxadiazol-2-yl)benzamide
L934-0507 Screening compound: 4-fluoro-N-(5-{5-oxo-1-[4-(trifluoromethoxy)phenyl]pyrrolidin-3-yl}-1,3,4-oxadiazol-2-yl)benzamide alternative view

Chemical Structure Depiction of ChemDiv screening compound L934-0507
4-fluoro-N-(5-{5-oxo-1-[4-(trifluoromethoxy)phenyl]pyrrolidin-3-yl}-1,3,4-oxadiazol-2-yl)benzamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

L934-0507

Molecular Formula

C20H14F4N4O4 (C20 H14 F4 N4 O4)

Compound Name

4-fluoro-N-(5-{5-oxo-1-[4-(trifluoromethoxy)phenyl]pyrrolidin-3-yl}-1,3,4-oxadiazol-2-yl)benzamide

IUPAC name

4-fluoro-N-(5-{5-oxo-1-[4-(trifluoromethoxy)phenyl]pyrrolidin-3-yl}-134-oxadiazol-2-yl)benzamide

SMILES

O=C(c(cc1)ccc1F)Nc1nnc(C(CC2=O)CN2c(cc2)ccc2OC(F)(F)F)o1

InChI

InChI=1S/C20H14F4N4O4/c21-13-3-1-11(2-4-13)17(30)25-19-27-26-18(31-19)12-9-16(29)28(10-12)14-5-7-15(8-6-14)32-20(22,23)24/h1-8,12H,9-10H2,(H,25,27,30)/t12-/m0/s1

InChI Key

LMRBHIUIUUSLAM-LBPRGKRZSA-N

MDL Number (MFCD)

MFCD15137617

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

450.35

Hydrogen Bond Acceptors Count

8.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

7.00

Number of Nitrogen and Oxygen Atoms

8

Partition Coefficient, logP

3.223

Distribution Coefficient, logD

0.638

Water Solubility, LogSw

-3.52

Polar Surface Area

77.845

Acid Dissociation Constant (pKa)

4.82

Base Dissociation Constant (pKb)

-1.37

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

20.00

L934-0507 in Drug Discovery

Included in Screening Libraries

Type II Kinase Inhibitors Library (6956 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Digestive system
  • Hemic and lymphatic
  • Endocrine
Targets:
  • Kinases

References: we are preparing a list of scientific research reports with L934-0507 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound L934-0507?
Check Price and Availability of L934-0507, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of L934-0507 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for L934-0507
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for L934-0507
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of L934-0507 available by request